EFDID: 337138EFD: View Filing

Issuer: Olema Pharmaceuticals, Inc. (0001750284) - D/A

Accession: 0001750284-20-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001750284
  • Entity Name:
    Olema Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    665 3RD STREET SUITE 250
    SAN FRANCISCO, CA 94107
  • Persons:
    Related Persons 7
    Cyrus Harmon
    Executive Officer, Director
    Frank McCormick
    Director
    Andrew Rappaport
    Director
    Gorjan Hrustanovic
    Director
    Graham Walmsley
    Director
    Peter Kushner
    Executive Officer
    Pamela Klein
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    06/23/2020
  • First Sale Date:
    03/13/2020
  • Offering Amount:
    $55,400,000
  • Amount Sold:
    $53,900,000
  • Amount Remaining:
    $1,500,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Series B Preferred stock and Common Stock Issuable upon conversion thereof; Series B Preferred stock issued upon conversion of promissory notes.
  • Sales Clarification:
    (b) includes $3,007,359 attributed to conversion of convertible promissory notes
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, NC
Inactive:CO
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Olema Pharmaceuticals, Inc./s/ Cyrus L. HarmonCyrus L. HarmonCEO2020-06-18
Related EDGAR Submissions
Type Edgar Date EFD: Accession
D/A Jun. 23, 2020 337138: 0001750284-20-000002 Olema Pharmaceuticals, Inc.
Offer Amount: $55,400,000
Amount Sold: $53,900,000
Remaining: $1,500,000
D Mar. 27, 2020 337138: 0001750284-20-000001 Olema Pharmaceuticals, Inc.
Offer Amount: $45,000,000
Amount Sold: $30,000,000
Remaining: $15,000,000